期刊文献+

重组人脑利钠肽对ST段抬高型心肌梗死再灌注损伤的保护作用 被引量:12

下载PDF
导出
摘要 目的探讨重组人脑利钠肽(rhBNP)对ST段抬高型心肌梗死(STEMI)再灌注损伤的保护作用。方法选择STEMI且直接行PCI的患者,分为对照组(28例)及加用rhBNP治疗组(30例)。对照组给予常规药物治疗,治疗组在常规药物治疗基础上,于PCI术前30 min左右给予rhBNP,按1.5μg/kg负荷剂量静脉注射(>3 min),随后以0.015μg·kg-1·min-1静脉滴注48 h。观察两组再灌注心律失常发生率,肌酸磷酸激酶(CK)及同工酶(CK-MB)的峰值,术后3个月的左室舒张末期直径(LVEDd)和左室射血分数(LVEF)。结果再灌注心律失常发生率显著少于对照组(P<0.05);治疗组的CK和CK-MB峰值明显低于对照组(P<0.001);应用rhBNP治疗组术后3个月的LVEDd明显低于对照组,LVEF明显优于对照组。结论 rhBNP能显著减轻STEMI患者心肌再灌注损伤,抑制心律失常,缩小梗死面积,有效抑制心室重构,改善心功能,起到心肌保护作用。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2013年第22期5582-5584,共3页 Chinese Journal of Gerontology
  • 相关文献

参考文献7

二级参考文献38

  • 1周玖瑶,李锐,廖雪珍,张英丰.环维黄杨星D抗垂体后叶素致心肌缺血作用机理研究[J].广州中医药大学学报,2005,22(6):454-457. 被引量:13
  • 2李世强,傅向华,刘君,谷新顺,张晶,樊欣娜,姜云发,苗青.静脉注射重组人脑利钠肽对急性心肌梗死伴心力衰竭患者的急性血流动力学效应的研究[J].中华心血管病杂志,2006,34(1):23-27. 被引量:102
  • 3孙涛,苏全生.自由基与心肌缺血/再灌注损伤[J].实用医院临床杂志,2006,3(4):94-96. 被引量:21
  • 4蔡洪流,方强.血浆B型利钠肽浓度对心力衰竭诊断及预后判断的作用[J].中华急诊医学杂志,2006,15(9):816-819. 被引量:23
  • 5D'Souza SP, Yellon DM, Martin C, et al. B- type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening [J]. Am J Physiol Heart Circ Physiol,2003 ;284 (5) : H1592-H600.
  • 6Tsuruda T, Boerrigter G, Huntley BK, et al. Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases [J]. Circ Res,2002;13(27) :1127-34.
  • 7Hama N, Itoh H,Shirakami G,et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardiol infarction [J]. Circulation, 1995 ;92 ( 6 ) : 1558-64.
  • 8Zhao W, Fan GC. Protection of peroxiredoxin Ⅱ on oxidative stress induced cardiomyocyte death and apoptosis[ J]. Basic Res Cardiol,2009 ; 104(4) :377-89.
  • 9Jiangui He,Yili Chen,Yiyi Huang,et al.Effect of long-term B-type natriuretic peptide treatment on left ventricular remodeling and function after myocardial infarction in rats.Eur J of Pharmac,2009,602:132-137.
  • 10Buikema H,Monnink SH,Tio RA,et al.Comparison of zofenopril and lisinopril to study the role of the sulfhydryl group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.Br J Pharmacol,2000,130:1999-2007.

共引文献1992

同被引文献82

  • 1尤华彦,吴小庆.重组人脑利尿钠肽辅助治疗慢性充血性心力衰竭273例疗效观察[J].山东医药,2009,49(51):69-70. 被引量:3
  • 2王如兴,李肖蓉,邵力正,羊镇宇,肖春晖,王强,杨光敏.B型利钠肽对心源性呼吸困难鉴别诊断界值的研究[J].临床荟萃,2004,19(22):1277-1279. 被引量:7
  • 3郭继鸿.心肌再灌注心电图[J].临床心电学杂志,2006,15(1):57-65. 被引量:29
  • 4谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 5Nagaya N, Nishikimi T, Goto Y, et al. Plasma brain natriuret- ic peptide is a biochemical marker for the prediction of pro- gressive ventricular remodeling after acute myocardial infarc- tion[ J]. Am Heart J,1998,135( 1 ) :21 -28.
  • 6Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B-natri- uretic peptide as a rapid, point-of-care test for screening pa- tients undergoing echocardiography to determine left ventric- ular dysfunction[ J]. Am Heart J ,2001,141 (3) :367 -374.
  • 7Chen HH, Martin FL, Gibbons R J, et al. Low-dose nesiritide in human anterior myocardial infarction suppresses aldoste- tone and preserves ventricular function and structure : a proof of concept study [ J ]. Heart,2009,95 ( 16 ) : 1 315 - 1 319.
  • 8Thygesen K, Alpert JS, Jaffe AS, et al. Third universal defi- nition of myocardial infarction[ J]. J Am Coll Cardiol,2012, 60(16) :1 581 -1 598.
  • 9Zijlstra F, Hoorntje JC, de Boer M J, et al. Long-term benefit of primary angioplasty as compared with thromholytic thera- py for acute myocardial infarction[ J]. N Engl J Med, 1999, 341(19) :1 413 -1 419.
  • 10Ryabova TR, Sokolov AA, Dudko VA, et al. Dynamics of left ventricular remodeling in patients with acute myocardial in- farction [ J ]. Kardiologiia, 2002,42 (9) : 30 - 34.

引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部